Cepheid Gets FDA Nod for Antimicrobial Resistance Test

The FDA cleared Cepheid's Xpert vanA test for the antimicrobial resistance gene most commonly associated with vancomycin-resistant enterococci.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories